|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 17.70 TWD | +3.21% |
|
+6.95% | -6.60% |
| 05-14 | Adimmune Corporation Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
| 03-31 | Adimmune Corporation Reports Earnings Results for the Full Year Ended December 31, 2025 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| ADIMMUNE CORPORATION | Biopharmaceuticals | +3.21% | +6.95% | -6.60% | +1.43% | -63.88% | 231M |  |  | |
- Stock Market
- Stocks
- 4142 Stock
- Charts Adimmune Corporation
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
